Further, EDSSPD3-iPSCs have applications not only in the elucidation of mechanisms underlying ZIP13-mediated biological events, but also in regenerative studies and pharmaceutical applications as a treatment approach for EDSSPD3. The gene discussed is SLC39A13; the disease is Ehlers-Danlos syndrome, spondylocheirodysplastic type.